Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Trials of Cell Phone Microscope to Begin in Africa

By LabMedica International staff writers
Posted on 14 Jul 2010
A functioning prototype of a cell phone microscope has been developed.

The telemedicine microscope captures an image with a lensless system. More...
This means that the microscope can be miniaturized (it weighs approximately 43 g) to the point where it fits on most cell phones, while remaining inexpensive enough for widespread use in developing countries, costing only about US$10 each.

Images are captured through a process called diffraction, or shadow-based, imaging. An ordinary light-emitting diode (LED) from the top illuminates the sample, and the detector array already installed in cell phone cameras captures the image, recording the patterns created by the shadows resulting from the LED light scattering off the cells in the sample. Because cells are semi-transparent, enough information is obtained from this type of imaging to detect subcellular elements, and to produce holographic images. By using an inexpensive LED light instead of the laser as typically required for holographic imaging, the size and cost are further reduced.

The cell phone microscope is easy to use and versatile. Samples (blood smears or saliva) are loaded into single-use chips that easily slide into the side of the microscope. Because the microscope uses the entire detector array to capture an image and has a relatively large aperture, it has a wide imaging field-of-view. Samples do not need to be precisely aligned for images to be captured, and the chance of debris clogging the light source is lessened.

"Cell phones present a tremendous opportunity in Global healthcare," remarked Aydogan Ozcan, assistant professor of electrical engineering at the University of California Los Angeles (UCLA) Henry Samueli School of Engineering and Applied Science (Los Angeles, CA, USA) and investigator at UCLA's California NanoSystems Institute, "We can leverage the fact that 80 % of the world's population lives in areas covered by cell phone networks to bridge the gaps left by a lack of health care infrastructure in developing countries."

The lensless imaging platform behind the cell phone microscope will be tested in real world trials. It received awards from the Bill & Melinda Gates Foundation, National Geographic, and the [U.S.] National Science Foundation (NSF).

The cover article of the July 2010 edition of the journal Lab on a Chip features the latest creation by the Prof. Ozcan's group.

Related Links:

UCLA Henry Samueli School of Engineering and Applied Science
UCLA's California NanoSystems Institute
Bill & Melinda Gates Foundation
[U.S.] National Science Foundation


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.